DERIVATIVE FINANCIAL INSTRUMENTS

Cash Flow Hedges

The Company has exposure to changes in foreign currency exchange rates related to anticipated cash flows associated with certain international inventory purchases. The Company periodically uses foreign currency forward exchange contracts to hedge against a portion of this exposure.

The Company also has exposure to interest rate volatility related to its term loans under the 2016 facilities. The Company has entered into interest rate swap agreements to hedge against a portion of this exposure. Please see Note 9, “Debt,” for a further discussion of the Company’s facilities and these agreements.

The Company records the foreign currency forward exchange contracts and interest rate contracts at fair value in its Consolidated Balance Sheets, and does not net the related assets and liabilities. Changes in fair value of the foreign currency forward exchange contracts associated with certain international inventory purchases and the interest rate contracts that are designated as effective hedging instruments (collectively referred to as “cash flow hedges”) are recorded in equity as a component of accumulated other comprehensive loss (“AOCL”). The cash flows from such hedges are presented in the same category in the Company’s Consolidated Statements of Cash Flows as the items being hedged. No amounts were excluded from effectiveness testing. There was no ineffective portion of cash flow hedges during the thirteen weeks ended April 30, 2017 and May 1, 2016.

Net Investment Hedge

The Company has exposure to changes in foreign currency exchange rates related to the value of its investments in foreign subsidiaries denominated in a currency other than the United States dollar. To hedge against a portion of this exposure, during the second quarter of 2016, the Company designated the carrying amount of its €350.0 million euro-denominated principal amount of 3 5/8% senior notes due 2024 (the “foreign currency borrowings”) that it had issued in the United States as a net investment hedge of its investments in certain of its foreign subsidiaries that use the euro as their functional currency. Please see Note 9, “Debt,” for a further discussion of the Company’s foreign currency borrowings.

The Company records the foreign currency borrowings at carrying value in its Consolidated Balance Sheets. The carrying value of the foreign currency borrowings is remeasured at the end of each reporting period to reflect changes in the foreign currency exchange spot rate. Since the foreign currency borrowings are designated as a net investment hedge, such remeasurement is recorded in equity as a component of AOCL. The fair value and the carrying value of the foreign currency borrowings designated as a net investment hedge were $398.8 million and $376.3 million, respectively, as of April 30, 2017 and $384.1 million and $367.5 million, respectively, as of January 29, 2017. The Company evaluates the effectiveness of its net investment hedge as of the beginning of each quarter. No amounts were excluded from effectiveness testing. There was no ineffective portion of the net investment hedge during the thirteen weeks ended April 30, 2017.

Undesignated Contracts

The Company records immediately in earnings changes in the fair value of hedges that are not designated as effective hedging instruments (“undesignated contracts”), including all of the foreign currency forward exchange contracts related to intercompany transactions and intercompany loans that are not of a long-term investment nature. Any gains and losses that are immediately recognized in earnings on such contracts are largely offset by the remeasurement of the underlying intercompany balances.

In addition, the Company has exposure to changes in foreign currency exchange rates related to the translation of the earnings of its subsidiaries denominated in a currency other than the United States dollar. To hedge against a portion of this exposure, beginning in the second quarter of 2016, the Company entered into several foreign currency option contracts. These contracts represent the Company’s purchase of euro put/United States dollar call options and Chinese yuan renminbi put/United States dollar call options.

The Company’s foreign currency option contracts are also undesignated contracts. As such, the changes in the fair value of these foreign currency option contracts are recognized immediately in earnings. This mitigates the effect of a strengthening United States dollar against the euro and Chinese yuan renminbi on the reporting of the Company’s euro-denominated and Chinese yuan renminbi-denominated earnings, respectively.

The Company does not use derivative or non-derivative financial instruments for trading or speculative purposes.

The following table summarizes the fair value and presentation of the Company’s derivative financial instruments in its Consolidated Balance Sheets:



(In millions)	Assets (Classified in Other Current Assets and Other Assets)						Liabilities (Classified in Accrued Expenses and Other Liabilities)
	4/30/17		1/29/17		5/1/16		4/30/17		1/29/17		5/1/16
Contracts designated as cash flow hedges:
Foreign currency forward exchange contracts (inventory purchases)	$	18.7	$	25.1	$	1.0	$	7.1	$	2.6	$	34.0
Interest rate contracts	—		—		—		4.0		7.1		18.4
Total contracts designated as cash flow hedges	18.7		25.1		1.0		11.1		9.7		52.4
Undesignated contracts:
Foreign currency forward exchange contracts	0.6		0.8		0.3		0.9		0.0		0.6
Foreign currency option contracts	1.7		3.2		—		—		—		—
Total undesignated contracts	2.3		4.0		0.3		0.9		0.0		0.6
Total	$	21.0	$	29.1	$	1.3	$	12.0	$	9.7	$	53.0

At April 30, 2017, the notional amount outstanding of foreign currency forward exchange contracts and foreign currency option contracts was $1,032.4 million and $150.0 million, respectively. Such contracts expire principally between May 2017 and September 2018.

The following table summarizes the effect of the Company’s hedges designated as cash flow and net investment hedging instruments:



	(Loss) Gain Recognized in Other Comprehensive Income						Gain (Loss) Reclassified from AOCL into Income (Expense)
(In millions)	(Loss) Gain Recognized in Other Comprehensive Income						Location	Amount

Thirteen Weeks Ended	4/30/17			5/1/16				4/30/17			5/1/16
Foreign currency forward exchange contracts (inventory purchases)	$	(7.8	)	$	(58.4	)	Cost of goods sold	$	4.4		$	4.7
Interest rate contracts	0.8			(0.1		)	Interest expense	(2.3		)	(2.4		)
Foreign currency borrowings (net investment hedge)	(8.6		)	—			N/A	—			—
Total	$	(15.6	)	$	(58.5	)		$	2.1		$	2.3

A net gain in AOCL on foreign currency forward exchange contracts at April 30, 2017 of $19.8 million is estimated to be reclassified in the next 12 months in the Company’s Consolidated Income Statement to costs of goods sold as the underlying inventory hedged by such forward exchange contracts is sold. In addition, a net loss in AOCL for interest rate contracts at April 30, 2017 of $4.0 million is estimated to be reclassified to interest expense within the next 12 months. Amounts recognized in AOCL for foreign currency borrowings would be recognized in earnings only upon the sale or liquidation of the hedged net investment.

The following table summarizes the effect of the Company’s undesignated contracts recognized in selling, general and administrative expenses in its Consolidated Income Statements:



(In millions)	Gain (Loss) Recognized in Income (Expense)
Thirteen Weeks Ended	4/30/17			5/1/16
Foreign currency forward exchange contracts	$	0.2		$	(3.8	)
Foreign currency option contracts	(2.6		)	—

The Company had no derivative financial instruments with credit risk-related contingent features underlying the related contracts as of April 30, 2017.